Savant Capital Management »

Aldeyra Therapeutics shares owned by Savant Capital Management

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Savant Capital Management from 13F filings

Historical chart of Savant Capital Management investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Savant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Savant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $752k 144k 5.22
2025-06-30 $552k 144k 3.83

More positions owned by Savant Capital Management

American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Intl High Profit (DIHP)
Dimensional Etf Trust Us Mktwide Value (DFUV)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Internatnal Val (DFIV)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Global Real Est (DFGR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Savant Capital Management

Top funds holding Aldeyra Therapeutics

Knoll Capital Management
Perceptive Advisors
BlackRock
Vanguard Group
Ardsley Advisory Partners
AQR Capital Management
D. E. Shaw & Co
Kingdon Capital Management
Geode Capital Management
Kennedy Capital Management
State Street Corporation
Jacobs Levy Equity Management
Acadian Asset Management
683 Capital Management
Morgan Stanley

View all funds holding Aldeyra Therapeutics